Home News AstraZeneca’s COVID-19 vaccine trials can resume in US

AstraZeneca’s COVID-19 vaccine trials can resume in US


Federal health regulators have greenlit the resumption of US studies of AstraZeneca’s clinical trial of its COVID-19 vaccine after it was put on hold for over a month, according to a report.

A person familiar with the matter told the news to the Wall Street Journal, which also reported Friday that it reviewed related materials.

The US Food and Drug Administration had finally completed its review of two cases of a possible neurological side effect that occurred in two people testing the shot, it was reported.

The agency told the UK-based pharmaceutical company on Friday that the late-stage trial in the US can resume, the Wall Street Journal reported, citing the unidentified person and materials.

The source told the news outlet that the FDA did not find that the vaccine was responsible for the two cases, though it couldn’t rule out a link either.

According to the person, the FDA plans to require researchers to inform study subjects of the cases and monitor them for any related neurological events like numbness, the report said.

A COVID-19 vaccine being developed by researchers at the Imperial College London and Oxford University.
A COVID-19 vaccine being developed by researchers at the Imperial College London and Oxford UniversityAP

AstraZeneca’s vaccine is being developed along with researchers at Oxford University.

Trials in the United Kingdom, Brazil and South Africa resumed last month even as the FDA continued its investigation into the case.

AstraZeneca’s vaccine is one of four potential coronavirus inoculations currently going through late-stage trials in the US.

The drug company’s vaccine accurately follows genetic instructions programmed into it by its developers at Oxford University, successfully provoking a powerful immune response, according to an analysis by independent scientists.

“Until now, the technology hasn’t been able to provide answers with such clarity, but we now know the vaccine is doing everything we expected and that is only good news in our fight against the illness,” said David Matthews, a virology expert at Bristol University who led the research.

“This is an important study as we are able to confirm that the genetic instructions underpinning this vaccine, which is being developed as fast as safely possible, are correctly followed when they get into a human cell,” he said.

With Post wires

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Dog abandoned in Mexico with heartfelt note needs forever home

A dog who was abandoned by his family and left chained to a bench alongside a heartfelt note has finally found a home.Boston,...

Jurgen Klopp is 'controlling the narrative' at Liverpool just like Sir Alex, says Rio Ferdinand

Jurgen Klopp is 'controlling the narrative' at Liverpool just like Sir...

Kate's sentimental throwback to romantic day for her and William wearing rare coat

She wore her black suede Tod’s pumps, £350, and merino wool black gloves, the Imogen style from Cornelia James, £95.A priceless detail in...

China overtakes the US to become EU's biggest trade partner  

China has overtaken the U.S. to become the EU's biggest trade partner while the rest of the world slides into the red due...

Recent Comments